Healthcare and life sciences investment in the UK is set for a rebound in 2025 as credit markets ease and investor sentiment strengthens, reports international law firm McDermott, Will & Emery Over the past few years, the combination of tight credit markets, staff shortages, wage inflation and digital transformation has driven something of a new…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
